Merck is selling at 95.40 as of the 2nd of January 2025; that is 0.32 percent increase since the beginning of the trading day. The stock's lowest day price was 95.1. Merck has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 12th of July 2023 and ending today, the 2nd of January 2025. Click here to learn more.
Although Merck's alpha and beta are two of the key measurements used to evaluate Merck's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Price Transformation Now
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.